Schellenberg Wittmer advised Boerhringer Ingelheim on the deal. Boehringer Ingelheim has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the operation. Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the sale of its Raxone®/idebenone business for all...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advises Santhera on license for North America for Vamorolone. Santhera Pharmaceuticals (SIX: SANN) has signed an exclusive license and collaboration agreement for vamorolone in...
You must be a Standard 1 Year member to access this content.
chellenberg Wittmer advised Santhera Pharmaceuticals on the deal. Swiss Biotech Santhera has entered an exclusive licence agreement with China-based Sperogenix Therapeutics for the development of Vamorolone...
You must be a Standard 1 Year member to access this content.
